skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial

Original Research

(2449) Views  (468) Full article downloads

Authors: Nader Nouri-Majalan, Reza Nafisi, Sarasadat Moghadasi-Mousavi

Published Date December 2008 Volume 2009:5 Pages 97 - 100
DOI: http://dx.doi.org/10.2147/VHRM.S4348

Nader Nouri-Majalan1, Reza Nafisi2, Sarasadat Moghadasi-Mousavi1

1Department of Nephrology; 2Department of Radiology, Shahid Sadoughi Medical University, Yazd, Iran

Background: Color Doppler sonography indices, such as resistive index (RI) and pulsatility index (PI), can predict arteriosclerosis of internal renal vessels after kidney transplantation. Angiotensin II receptor antagonists, however, may have antiatherogenic effects. We therefore assessed the effects of losartan on RIs of renal allografts.

Methods: We compared duplex sonographic measurements in renal allograft recipients (30 males, 20 females) from living donors randomized to a losartan (25 mg twice daily) or a control group.

Results: The patients in the two groups had similar baseline characteristics, and 49 (24 in the losartan and 25 in the control group) completed 12 months of follow-up. After 12 months, the losartan and control groups did not differ significantly in mean RI (0.71 ± 0.06 vs 0.69 ± 0.07, P = 0.4) or PI (1.3 ± 0.25 vs 1.29 ± 0.28, P = 0.8) of the intrarenal artery and mean RI (0.74 ± 0.07 vs 0.72 ± 0.07, P = 0.3) and PI (1.5 ± 0.3 vs 1.4 ± 0.34, P = 0.3) of the main artery.

Conclusions: Losartan had no effect on Doppler sonography indices. Longer follow-up, however, may be needed to confirm this finding.

Keywords: Doppler ultrasonography, kidney transplantation, losartan






 

Other articles by Dr Nader Nouri-Majalan



Readers of this article also read:

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts
Comparative assessment of angiotensin receptor blockers in different clinical settings
Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University